ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $237,710 | +3.4% | 11,000 | -7.6% | 0.00% | 0.0% |
| Q3 2022 | $230,000 | -55.4% | 11,900 | -54.2% | 0.00% | 0.0% |
| Q2 2022 | $516,000 | -60.8% | 26,000 | -41.2% | 0.00% | -75.0% |
| Q1 2022 | $1,318,000 | +22.7% | 44,200 | -4.1% | 0.00% | +33.3% |
| Q4 2021 | $1,074,000 | -51.4% | 46,100 | -35.0% | 0.00% | -50.0% |
| Q3 2021 | $2,212,000 | -59.1% | 70,900 | -53.8% | 0.01% | -57.1% |
| Q2 2021 | $5,404,000 | -27.6% | 153,600 | -27.5% | 0.01% | -33.3% |
| Q1 2021 | $7,469,000 | -1.3% | 211,900 | +5.1% | 0.02% | +5.0% |
| Q4 2020 | $7,566,000 | +486.1% | 201,700 | +421.2% | 0.02% | +400.0% |
| Q3 2020 | $1,291,000 | +125.7% | 38,700 | +79.2% | 0.00% | +100.0% |
| Q2 2020 | $572,000 | +105.8% | 21,600 | +27.1% | 0.00% | +100.0% |
| Q1 2020 | $278,000 | +6.1% | 17,000 | +65.0% | 0.00% | 0.0% |
| Q4 2019 | $262,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |